Medtech fundings in August 2015

By PatrickDriscoll

August 5, 2015

1 Mins read

88

0

Medtech fundings for August 2015 stand at $88 million, led by the $50 million funding of InVivo Therapeutics Corp.

Below are the top fundings for the month thus far. (Revisit and reload this post during August for new fundings during the month.)

Medtech fundings for August 2015 stand at $88 million, led by the $50 million funding of InVivo Therapeutics Corp.

Below are the top fundings for the month thus far. (Revisit and reload this post during August for new fundings during the month.)

COMPANY, FUNDING	PRODUCT/TECHNOLOGY
InVivo Therapeutics Corp. has raised $50 million in equity funding from Cowan and Company according to the company	Biomaterial scaffold for treatment of spinal cord injury
LifeBond Ltd. has raised $27 million in a Series D round of funding according to the company	Bio-surgical medical devices for tissue repair

For the complete list of medtech fundings in August 2015, see link.

For a historical list of the individual fundings in medtech, by month, since 2009, see link.

88

0

183 posts

PatrickDriscoll

About author

I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Articles